The U.S. Food and Drug Administration approved a new drug for the treatment of schizophrenia in adults. Dr. Darien Sutton explains.
2025-11-01
A nationwide recall affects more than 500,000 bottles of a common blood pressure drug after ...
BioGen’s “Aduhelm” is a monthly injection intended to slow cognitive decline in patients with early ...